Core Viewpoint - The Hong Kong stock market is experiencing a surge in IPO activity, with multiple companies set to list in the coming days, indicating a robust market environment for new listings [1][3][18]. Group 1: Upcoming IPOs - On June 30, six companies announced their IPOs, with plans to list between June 30 and July 4, 2025 [1][3]. - The companies planning to list include Lens Technology, Fortior, Xunzhong Communication, Jizhi Jia, Dazhong Oral, and Shougang Longze, with Lens Technology and Fortior being A-share listed companies [1][3]. - Three companies, including Taide Pharmaceutical, Yunzhisheng, and IFBH, successfully listed on June 30, 2025, with Taide Pharmaceutical's share price set at 30.6 HKD [1][4]. Group 2: Financial Performance of Listed Companies - Yunzhisheng reported revenues of approximately 601 million RMB, 727 million RMB, and 939 million RMB for 2022, 2023, and 2024, respectively, with net losses of 375 million RMB, 376 million RMB, and 454 million RMB [4][6]. - Taide Pharmaceutical raised approximately 514 million HKD, with a net amount of about 429 million HKD after expenses, and secured two cornerstone investors contributing a total of 10 million USD [8]. - IFBH raised around 1.158 billion HKD, with a net amount of approximately 1.074 billion HKD, and is recognized as the second-largest coconut water beverage company globally [8]. Group 3: Market Trends and Future Outlook - The Hong Kong stock exchange has seen over 40 new listings in the first half of 2025, a significant increase compared to the same period in 2024, with total fundraising exceeding 100 billion HKD [17]. - The market is expected to remain active, with more companies preparing for IPOs, including those that have already submitted applications [17][18]. - The trend indicates a growing interest from A-share listed companies to enter the Hong Kong market, with over 70 companies submitting applications in June 2025 alone [17].

Core Viewpoint - The article provides an overview of upcoming IPOs in Hong Kong, highlighting key companies, their financials, and market positions. Group 1: CaoCao Inc. (曹操出行) - CaoCao Inc. plans to list on the Hong Kong Stock Exchange on June 25, 2025, with the stock code "2643" [3] - The company aims to issue 44.18 million shares globally, with 4.42 million shares for Hong Kong and 39.76 million shares for international investors [3] - CaoCao has secured 6 cornerstone investors, raising approximately HKD 952 million, including investments from Mercedes-Benz and other firms [3] - The expected IPO proceeds are HKD 1.853 billion, with a valuation of approximately HKD 22.823 billion [3] - Established in 2015, CaoCao is one of China's largest ride-hailing platforms, covering 136 cities and expanding to 85 new cities in 2024 [4] - The company's Gross Transaction Value (GTV) for 2023 and 2024 is projected at CNY 12.2 billion and CNY 17 billion, reflecting growth rates of 37.5% and 38.8% respectively [4] - In Q1 2024, CaoCao's GTV reached CNY 4.8 billion, a 54.9% increase year-on-year [4] - The company operates a fleet of over 34,000 customized vehicles, the largest among similar platforms in China [4] - CaoCao launched an autonomous driving platform in February 2024, with plans to introduce L4 Robotaxi models by the end of 2026 [5] - Revenue for 2022 to 2024 is reported at CNY 7.631 billion, CNY 10.668 billion, and CNY 14.657 billion, with a gross margin improvement from 5.8% in 2023 to 8.1% in 2024 [5][6] Group 2: SAINT BELLA Inc. (圣贝拉) - SAINT BELLA plans to list on the Hong Kong Stock Exchange on June 26, 2025, with the stock code "2508" [8] - The company intends to issue 95.42 million shares, with a maximum fundraising target of HKD 627 million and a valuation of HKD 3.918 billion [8] - SAINT BELLA has attracted 7 cornerstone investors, raising approximately HKD 323 million [8] - The company operates 96 high-end maternity centers under various brands, making it the largest postpartum care group in China and Asia [9] - Revenue from 2022 to 2024 is reported at CNY 472 million, CNY 560 million, and CNY 799 million, with a significant increase in contract values across its business lines [10] Group 3: Zhou Liu Fu (周六福) - Zhou Liu Fu plans to list on the Hong Kong Stock Exchange on June 26, 2025, with the stock code "6168" [12] - The company aims to issue 46.81 million shares, with expected proceeds of HKD 1.123 billion and a valuation of HKD 10.213 billion [13] - Zhou Liu Fu has secured 8 cornerstone investors, raising approximately HKD 573 million [13] - Established in 2004, Zhou Liu Fu operates 4,129 stores across 31 provinces, ranking among the top five jewelry brands in China [14] - Revenue from 2022 to 2024 is reported at CNY 3.102 billion, CNY 5.150 billion, and CNY 5.718 billion, with a compound annual growth rate of 35.8% [14][15] Group 4: Yunzhisheng (云知声) - Yunzhisheng plans to list on the Hong Kong Stock Exchange on June 30, 2025, with the stock code "9678" [17] - The company aims to issue 1.56 million shares, with a fundraising target of up to HKD 320 million and a valuation between HKD 11.7 billion and HKD 14.5 billion [18] - Yunzhisheng has attracted 3 cornerstone investors, raising approximately HKD 95.5 million [19] - Founded in 2012, Yunzhisheng is a leader in AGI technology and has developed a large language model, UniCore, and its successor, the Shan Hai model [20][21] - Revenue from 2022 to 2024 is reported at CNY 601 million, CNY 727 million, and CNY 939 million, with a compound annual growth rate of 25% [22] Group 5: IFBH Limited (if) - IFBH Limited plans to list on the Hong Kong Stock Exchange on June 30, 2025, with the stock code "6603" [25] - The company intends to issue 41.67 million shares, with a maximum fundraising target of HKD 1.158 billion and a valuation of approximately HKD 7.4 billion [26] - IF is the second-largest coconut water beverage company globally, with a market share of approximately 34% in China [27] - Revenue for 2023 and 2024 is reported at USD 87 million and USD 158 million, reflecting a growth rate of 80.3% [28]

据招股书，瀚天天成是全球碳化硅(SiC)外延行业的领导者和革新者。根据灼识咨询的报告，自 2023年来，按年销售片数计，瀚天天成是全球最大的碳化硅 外延供应商，2024年的市场份额超过30%。 财务方面，于2022年度、2023年度、2024年度，瀚天天成收入分别约4.41亿元、11.43亿元、9.74亿元人民币；同期，年内全面收益总额分别为1.43亿元、 1.22亿元、1.66亿元人民币。 2）4月9日，IFBH Limited递表港交所主板，中信证券为独家保荐人。 招股书显示，IFBH Limited是一家植根泰国、快速增长的即饮饮料及即食食品公司。公司自2020年起在中国内地椰子水饮料市场连续五年蝉联榜首，2024年 市场占有率约34%，超越第二大竞争对手七倍以上。 财务方面，于2023年、2024年，IFBH Limited实现收益分别为8744.2万、约1.58亿美元；同期，期/年内溢利分别为1675.4万、3331.6万美元。 3）4月10日，吉宏股份向港交所递交招股书，，联席保荐人为中金和招银国际。 智通财经4月13日讯（编辑 冯轶）智通财经为您带来每周港股新股资讯。 截至发稿，本周(4月7日- ...